Atlas Trials

Impact of CES1 Genotype on Metabolism of Methylphenidate

Clinical trial NCT02147535 · COMPLETED

Trial details

NCT number
NCT02147535
Sponsor
Bispebjerg Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Carboxylesterase 1 (CES1) GenotypeCES1 Activity
Start date
2014-03-01
Primary completion
2014-08-01
Enrollment
78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.